SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
68 hedge funds and large institutions have $321M invested in Syros Pharmaceuticals, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+3
Holders Change %
+4.62%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
14
Increased
35
Reduced
14
Closed
9
Calls
$931K
Puts
$3K
Net Calls
+$928K
Net Calls Change
+$681K
Top Buyers
1 |
NAMA
Nikko Asset Management Americas
New York
|
+$21.3M |
2 |
RG
Redmile Group
San Francisco,
California
|
+$18.3M |
3 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$10.1M |
4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$8.38M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.99M |